class: top, center, title-slide # Single Case Experimental Design #1 ## A workshop for routine clinicians - Day 1: planning, conducting and reporting ### University of Sheffield - Clinical and Applied Psychology Unit --- class: center, middle, split-three, about-me-slide background-image: url(uos.png), url(pearls.jpg) background-position:5% 95%, 98% 96% background-size: 110px 50px, 10% .column.bg-main1[.content[ <img style="border-radius: 50%;" src="https://catalyse.uk.com/wp-content/uploads/sites/3/2015/10/SKcrop.jpg" width="150px"/> ### Steve Kellett #### Clinical Psychologist .fade[Sheffied Health & Social Care<br> NHS Foundation Trust] [<svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M464 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h416c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm0 48v40.805c-22.422 18.259-58.168 46.651-134.587 106.49-16.841 13.247-50.201 45.072-73.413 44.701-23.208.375-56.579-31.459-73.413-44.701C106.18 199.465 70.425 171.067 48 152.805V112h416zM48 400V214.398c22.914 18.251 55.409 43.862 104.938 82.646 21.857 17.205 60.134 55.186 103.062 54.955 42.717.231 80.509-37.199 103.053-54.947 49.528-38.783 82.032-64.401 104.947-82.653V400H48z"></path></svg>](mailto:s.kellett@sheffield.ac.uk) [<svg viewBox="0 0 448 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M0 32v448h448V32H0zm262.2 334.4c-6.6 3-33.2 6-50-14.2-9.2-10.6-25.3-33.3-42.2-63.6-8.9 0-14.7 0-21.4-.6v46.4c0 23.5 6 21.2 25.8 23.9v8.1c-6.9-.3-23.1-.8-35.6-.8-13.1 0-26.1.6-33.6.8v-8.1c15.5-2.9 22-1.3 22-23.9V225c0-22.6-6.4-21-22-23.9V193c25.8 1 53.1-.6 70.9-.6 31.7 0 55.9 14.4 55.9 45.6 0 21.1-16.7 42.2-39.2 47.5 13.6 24.2 30 45.6 42.2 58.9 7.2 7.8 17.2 14.7 27.2 14.7v7.3zm22.9-135c-23.3 0-32.2-15.7-32.2-32.2V167c0-12.2 8.8-30.4 34-30.4s30.4 17.9 30.4 17.9l-10.7 7.2s-5.5-12.5-19.7-12.5c-7.9 0-19.7 7.3-19.7 19.7v26.8c0 13.4 6.6 23.3 17.9 23.3 14.1 0 21.5-10.9 21.5-26.8h-17.9v-10.7h30.4c0 20.5 4.7 49.9-34 49.9zm-116.5 44.7c-9.4 0-13.6-.3-20-.8v-69.7c6.4-.6 15-.6 22.5-.6 23.3 0 37.2 12.2 37.2 34.5 0 21.9-15 36.6-39.7 36.6z"></path></svg>](https://www.researchgate.net/profile/Stephen-Kellett) ]] .column.bg-main2[.content[ <img style="border-radius: 50%;" src="https://pbs.twimg.com/profile_images/1235537191683723265/Qo6rZ317_400x400.jpg" width="150px"/> ### Mel Simmonds-Buckley #### Researcher .fade[University of Sheffield] [<svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M464 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h416c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm0 48v40.805c-22.422 18.259-58.168 46.651-134.587 106.49-16.841 13.247-50.201 45.072-73.413 44.701-23.208.375-56.579-31.459-73.413-44.701C106.18 199.465 70.425 171.067 48 152.805V112h416zM48 400V214.398c22.914 18.251 55.409 43.862 104.938 82.646 21.857 17.205 60.134 55.186 103.062 54.955 42.717.231 80.509-37.199 103.053-54.947 49.528-38.783 82.032-64.401 104.947-82.653V400H48z"></path></svg>](mailto:m.simmonds-buckley@sheffield.ac.uk) [<svg viewBox="0 0 640 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M622.34 153.2L343.4 67.5c-15.2-4.67-31.6-4.67-46.79 0L17.66 153.2c-23.54 7.23-23.54 38.36 0 45.59l48.63 14.94c-10.67 13.19-17.23 29.28-17.88 46.9C38.78 266.15 32 276.11 32 288c0 10.78 5.68 19.85 13.86 25.65L20.33 428.53C18.11 438.52 25.71 448 35.94 448h56.11c10.24 0 17.84-9.48 15.62-19.47L82.14 313.65C90.32 307.85 96 298.78 96 288c0-11.57-6.47-21.25-15.66-26.87.76-15.02 8.44-28.3 20.69-36.72L296.6 284.5c9.06 2.78 26.44 6.25 46.79 0l278.95-85.7c23.55-7.24 23.55-38.36 0-45.6zM352.79 315.09c-28.53 8.76-52.84 3.92-65.59 0l-145.02-44.55L128 384c0 35.35 85.96 64 192 64s192-28.65 192-64l-14.18-113.47-145.03 44.56z"></path></svg>](https://scholar.google.com/citations?user=T85W7TYAAAAJ&hl=en) [<svg viewBox="0 0 448 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M0 32v448h448V32H0zm262.2 334.4c-6.6 3-33.2 6-50-14.2-9.2-10.6-25.3-33.3-42.2-63.6-8.9 0-14.7 0-21.4-.6v46.4c0 23.5 6 21.2 25.8 23.9v8.1c-6.9-.3-23.1-.8-35.6-.8-13.1 0-26.1.6-33.6.8v-8.1c15.5-2.9 22-1.3 22-23.9V225c0-22.6-6.4-21-22-23.9V193c25.8 1 53.1-.6 70.9-.6 31.7 0 55.9 14.4 55.9 45.6 0 21.1-16.7 42.2-39.2 47.5 13.6 24.2 30 45.6 42.2 58.9 7.2 7.8 17.2 14.7 27.2 14.7v7.3zm22.9-135c-23.3 0-32.2-15.7-32.2-32.2V167c0-12.2 8.8-30.4 34-30.4s30.4 17.9 30.4 17.9l-10.7 7.2s-5.5-12.5-19.7-12.5c-7.9 0-19.7 7.3-19.7 19.7v26.8c0 13.4 6.6 23.3 17.9 23.3 14.1 0 21.5-10.9 21.5-26.8h-17.9v-10.7h30.4c0 20.5 4.7 49.9-34 49.9zm-116.5 44.7c-9.4 0-13.6-.3-20-.8v-69.7c6.4-.6 15-.6 22.5-.6 23.3 0 37.2 12.2 37.2 34.5 0 21.9-15 36.6-39.7 36.6z"></path></svg>](https://www.researchgate.net/profile/Mel-Simmonds-Buckley) ]] .column.bg-main3[.content[ <img style="border-radius: 50%;" src="https://pbs.twimg.com/profile_images/1434417640920002563/ZS62zhXl_400x400.jpg" width="150px"/> ### Chris Gaskell #### Clinical Psychologist .fade[Salford Royal<br> NHS Foundation Trust] [<svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"></path></svg> ](https://twitter.com/chrisgaskell92) [<svg viewBox="0 0 496 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"></path></svg>](https://github.com/chris-gaskell) [<svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M464 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h416c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm0 48v40.805c-22.422 18.259-58.168 46.651-134.587 106.49-16.841 13.247-50.201 45.072-73.413 44.701-23.208.375-56.579-31.459-73.413-44.701C106.18 199.465 70.425 171.067 48 152.805V112h416zM48 400V214.398c22.914 18.251 55.409 43.862 104.938 82.646 21.857 17.205 60.134 55.186 103.062 54.955 42.717.231 80.509-37.199 103.053-54.947 49.528-38.783 82.032-64.401 104.947-82.653V400H48z"></path></svg>](mailto:chris-gaskell@hotmail.co.uks) [<svg viewBox="0 0 640 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M622.34 153.2L343.4 67.5c-15.2-4.67-31.6-4.67-46.79 0L17.66 153.2c-23.54 7.23-23.54 38.36 0 45.59l48.63 14.94c-10.67 13.19-17.23 29.28-17.88 46.9C38.78 266.15 32 276.11 32 288c0 10.78 5.68 19.85 13.86 25.65L20.33 428.53C18.11 438.52 25.71 448 35.94 448h56.11c10.24 0 17.84-9.48 15.62-19.47L82.14 313.65C90.32 307.85 96 298.78 96 288c0-11.57-6.47-21.25-15.66-26.87.76-15.02 8.44-28.3 20.69-36.72L296.6 284.5c9.06 2.78 26.44 6.25 46.79 0l278.95-85.7c23.55-7.24 23.55-38.36 0-45.6zM352.79 315.09c-28.53 8.76-52.84 3.92-65.59 0l-145.02-44.55L128 384c0 35.35 85.96 64 192 64s192-28.65 192-64l-14.18-113.47-145.03 44.56z"></path></svg>](https://scholar.google.com/citations?user=gQuNwfYAAAAJ&hl=en&authuser=1&oi=ao) [<svg viewBox="0 0 448 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"> <path d="M0 32v448h448V32H0zm262.2 334.4c-6.6 3-33.2 6-50-14.2-9.2-10.6-25.3-33.3-42.2-63.6-8.9 0-14.7 0-21.4-.6v46.4c0 23.5 6 21.2 25.8 23.9v8.1c-6.9-.3-23.1-.8-35.6-.8-13.1 0-26.1.6-33.6.8v-8.1c15.5-2.9 22-1.3 22-23.9V225c0-22.6-6.4-21-22-23.9V193c25.8 1 53.1-.6 70.9-.6 31.7 0 55.9 14.4 55.9 45.6 0 21.1-16.7 42.2-39.2 47.5 13.6 24.2 30 45.6 42.2 58.9 7.2 7.8 17.2 14.7 27.2 14.7v7.3zm22.9-135c-23.3 0-32.2-15.7-32.2-32.2V167c0-12.2 8.8-30.4 34-30.4s30.4 17.9 30.4 17.9l-10.7 7.2s-5.5-12.5-19.7-12.5c-7.9 0-19.7 7.3-19.7 19.7v26.8c0 13.4 6.6 23.3 17.9 23.3 14.1 0 21.5-10.9 21.5-26.8h-17.9v-10.7h30.4c0 20.5 4.7 49.9-34 49.9zm-116.5 44.7c-9.4 0-13.6-.3-20-.8v-69.7c6.4-.6 15-.6 22.5-.6 23.3 0 37.2 12.2 37.2 34.5 0 21.9-15 36.6-39.7 36.6z"></path></svg>](https://www.researchgate.net/profile/Chris-Gaskell-2) ]] ??? - SCR is about diligently evaluation if what has been done, works. - Its about seeing if the change you wanted to see, occurred. - Clinicians are fantastic and delivering interventions but we sometimes fall short on the evaluation side. And this does us a disservice, Because you may have changed something incredibly big in someone's life, But you didn't document, record or evaluate it. - So how do we do that, we ask the patient and we were record what what they say. Or better yet, we ask the patient and they record for them self. This is important because We want them to be invested in the process of monitoring if change has occurred. - So to summarise single case research is about finding a problem recording some information introducing intervention as seen anything changes. --- class: left background-image: url(uos.png), url(pearls.jpg) background-position:5% 95%, 98% 96% background-size: 110px 50px, 10% # What is it? -- .large[ 1. Find a problem 2. Start measuring it 3. Introduce an intervention 4. Check for change ] ~ Repeat options 3 + 4 (optional) --- layout: false class: inverse2, top, center # Discussion Task .left[ ## **Is change important?** .large[Q. To what extent is change important?] .large[Q. Should we measure change? why?] .large[Q. How can we demonstrate if change has occurred?] .large[Q. What is our relationship to measuring change?] .large[Q. What are the implications of not measuring change?]] .footnote[ .large[*10-15 minute discussion task in pairs] ] --- class: center, top, split-three, inverse background-image: url(https://rin.org.uk/resource/resmgr/nav21/nav21_map.png) background-position:8% 70% background-size: 375px 300px .column.bg-main1[.content[.right[ <img style="border-radius: 50%;" src=" " width="150px"/> # <svg viewBox="0 0 496 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M347.94 129.86L203.6 195.83a31.938 31.938 0 0 0-15.77 15.77l-65.97 144.34c-7.61 16.65 9.54 33.81 26.2 26.2l144.34-65.97a31.938 31.938 0 0 0 15.77-15.77l65.97-144.34c7.61-16.66-9.54-33.81-26.2-26.2zm-77.36 148.72c-12.47 12.47-32.69 12.47-45.16 0-12.47-12.47-12.47-32.69 0-45.16 12.47-12.47 32.69-12.47 45.16 0 12.47 12.47 12.47 32.69 0 45.16zM248 8C111.03 8 0 119.03 0 256s111.03 248 248 248 248-111.03 248-248S384.97 8 248 8zm0 448c-110.28 0-200-89.72-200-200S137.72 56 248 56s200 89.72 200 200-89.72 200-200 200z"></path></svg> Navigating these slides ]]] .column.bg-main2[.content[ <img style="border-radius: 50%;" src=" " width="150px"/> .Large[.bold[ ### Day 1 [Aims + Intro](#aims-slide) [Why](#why-slide) [Measures](#measures-slide) [Designs](#designs-slide) [Setting it up](#stages-slide)] ]]] -- .column.bg-main3[.content[ <img style="border-radius: 50%;" src=" " width="150px"/> .Large[.Bold[ ### Day 2 .bold[ Analysis Practice <a href="https://sced-for-clinicians.netlify.app/resources/"> Resources </a> ] ]]]] -- .footnote[.Large[**Note**: Underlined .white[.underline[white]] and .my-hot-white[.my-blue[.underline[blue]]] text are hyperlinks!] ] --- name: contents-slide class: inverse background-image: background-position: background-size: # <svg viewBox="0 0 496 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M347.94 129.86L203.6 195.83a31.938 31.938 0 0 0-15.77 15.77l-65.97 144.34c-7.61 16.65 9.54 33.81 26.2 26.2l144.34-65.97a31.938 31.938 0 0 0 15.77-15.77l65.97-144.34c7.61-16.66-9.54-33.81-26.2-26.2zm-77.36 148.72c-12.47 12.47-32.69 12.47-45.16 0-12.47-12.47-12.47-32.69 0-45.16 12.47-12.47 32.69-12.47 45.16 0 12.47 12.47 12.47 32.69 0 45.16zM248 8C111.03 8 0 119.03 0 256s111.03 248 248 248 248-111.03 248-248S384.97 8 248 8zm0 448c-110.28 0-200-89.72-200-200S137.72 56 248 56s200 89.72 200 200-89.72 200-200 200z"></path></svg> Navigating these slides <svg viewBox="0 0 576 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M528 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h480c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm8 336c0 4.411-3.589 8-8 8H48c-4.411 0-8-3.589-8-8V112c0-4.411 3.589-8 8-8h480c4.411 0 8 3.589 8 8v288zM170 270v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm-336 82v-28c0-6.627-5.373-12-12-12H82c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm384 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zM122 188v-28c0-6.627-5.373-12-12-12H82c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm-98 158v-16c0-6.627-5.373-12-12-12H180c-6.627 0-12 5.373-12 12v16c0 6.627 5.373 12 12 12h216c6.627 0 12-5.373 12-12z"></path></svg> .large[.white[Keyoard shortcuts] - Press 'h'.] <svg viewBox="0 0 576 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M288 0c-69.59 0-126 56.41-126 126 0 56.26 82.35 158.8 113.9 196.02 6.39 7.54 17.82 7.54 24.2 0C331.65 284.8 414 182.26 414 126 414 56.41 357.59 0 288 0zm0 168c-23.2 0-42-18.8-42-42s18.8-42 42-42 42 18.8 42 42-18.8 42-42 42zM20.12 215.95A32.006 32.006 0 0 0 0 245.66v250.32c0 11.32 11.43 19.06 21.94 14.86L160 448V214.92c-8.84-15.98-16.07-31.54-21.25-46.42L20.12 215.95zM288 359.67c-14.07 0-27.38-6.18-36.51-16.96-19.66-23.2-40.57-49.62-59.49-76.72v182l192 64V266c-18.92 27.09-39.82 53.52-59.49 76.72-9.13 10.77-22.44 16.95-36.51 16.95zm266.06-198.51L416 224v288l139.88-55.95A31.996 31.996 0 0 0 576 426.34V176.02c0-11.32-11.43-19.06-21.94-14.86z"></path></svg> .large[.white[Overview slides] - Press 'o'.] <svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M290.74 93.24l128.02 128.02-277.99 277.99-114.14 12.6C11.35 513.54-1.56 500.62.14 485.34l12.7-114.22 277.9-277.88zm207.2-19.06l-60.11-60.11c-18.75-18.75-49.16-18.75-67.91 0l-56.55 56.55 128.02 128.02 56.55-56.55c18.75-18.76 18.75-49.16 0-67.91z"></path></svg> .large[.white[Scribble on slides] - Press 's'.] -- .footnote[ .pull-left[ .small[ .large[<svg viewBox="0 0 384 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M369.9 97.9L286 14C277 5 264.8-.1 252.1-.1H48C21.5 0 0 21.5 0 48v416c0 26.5 21.5 48 48 48h288c26.5 0 48-21.5 48-48V131.9c0-12.7-5.1-25-14.1-34zM332.1 128H256V51.9l76.1 76.1zM48 464V48h160v104c0 13.3 10.7 24 24 24h104v288H48zm250.2-143.7c-12.2-12-47-8.7-64.4-6.5-17.2-10.5-28.7-25-36.8-46.3 3.9-16.1 10.1-40.6 5.4-56-4.2-26.2-37.8-23.6-42.6-5.9-4.4 16.1-.4 38.5 7 67.1-10 23.9-24.9 56-35.4 74.4-20 10.3-47 26.2-51 46.2-3.3 15.8 26 55.2 76.1-31.2 22.4-7.4 46.8-16.5 68.4-20.1 18.9 10.2 41 17 55.8 17 25.5 0 28-28.2 17.5-38.7zm-198.1 77.8c5.1-13.7 24.5-29.5 30.4-35-19 30.3-30.4 35.7-30.4 35zm81.6-190.6c7.4 0 6.7 32.1 1.8 40.8-4.4-13.9-4.3-40.8-1.8-40.8zm-24.4 136.6c9.7-16.9 18-37 24.7-54.7 8.3 15.1 18.9 27.2 30.1 35.5-20.8 4.3-38.9 13.1-54.8 19.2zm131.6-5s-5 6-37.3-7.8c35.1-2.6 40.9 5.4 37.3 7.8z"></path></svg>] This presentation is available as a <a href="https://chris-gaskell.github.io/uos-sced/day-one/output/day-one.pdf">pdf</a> and <a href="https://chris-gaskell.github.io/uos-sced/day-one/output/day-one.pptx">powerpoint</a> .large[<svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M464 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h416c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm0 48v40.805c-22.422 18.259-58.168 46.651-134.587 106.49-16.841 13.247-50.201 45.072-73.413 44.701-23.208.375-56.579-31.459-73.413-44.701C106.18 199.465 70.425 171.067 48 152.805V112h416zM48 400V214.398c22.914 18.251 55.409 43.862 104.938 82.646 21.857 17.205 60.134 55.186 103.062 54.955 42.717.231 80.509-37.199 103.053-54.947 49.528-38.783 82.032-64.401 104.947-82.653V400H48z"></path></svg>] If you find any problems with these slides then e-mail <a href="mailto:cgaskell1@sheffield.ac.uk">Chris</a>. All resources available on the accompanying <a href="https://sced-for-clinicians.netlify.app">teaching website</a> ]]] -- .pull-right[ .center[ <figure> <img src="https://spcanelon.github.io/xaringan-basics-and-beyond/slides/img/hex-xaringan.png" alt="Trulli" style="width:45%"> <img src="https://psyteachr.github.io/hack-your-data/img/rmarkdown.png" alt="Trulli" style="width:45%"> <figcaption>.small[.right[Slides made using Xaringan and R Markdown.]]</figcaption> </figure> ]] --- layout: true background-image: url(uos.png), url(pearls.jpg) background-position:5% 95%, 98% 96% background-size: 110px 50px, 10% --- name: aims-slide # Aims of the workshop .large[ + Become .blue[familiar] with the requirements of single case design. + and the specific requirements for the assignment. + Appreciate the links between .blue[practice-based evidence] and SCED methodology. + .blue[Understand] the basic features of the SCED designs. + Consider ways of engaging clients in SCED. + Appreciate the .blue[potential] of SCED methodology. ] --- layout: true background-image: url(uos.png), url(pearls.jpg) background-position:5% 95%, 98% 96% background-size: 110px 50px, 10% --- # Aims of the workshop .large[ + .blue[Review the application] of SCED methodology within clinical research and practice. + Consider potential .blue[practical difficulties] in implementation of SCED. + Provide .blue[practical experience] of design and analysis. + Foresee potential difficulties and .blue[trouble-shoot]. ] --- exclude: true # Hopes for the workshop ## Include <svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:grey;height:0.8em;" xmlns="http://www.w3.org/2000/svg"> <path d="M290.74 93.24l128.02 128.02-277.99 277.99-114.14 12.6C11.35 513.54-1.56 500.62.14 485.34l12.7-114.22 277.9-277.88zm207.2-19.06l-60.11-60.11c-18.75-18.75-49.16-18.75-67.91 0l-56.55 56.55 128.02 128.02 56.55-56.55c18.75-18.76 18.75-49.16 0-67.91z"></path></svg> .can-edit.key-firstSlideTitleunique[ - Write - Here - And - We - Will - Come - Back ] --- # A note on the assignment .pull-left[ + Conduct a SCED of psychological treatment. + Any design is permissible (we will teach you all the methods). We are going to give you everything you need in order to be able to pass your assignment.] .pull-right[<img src="https://i.imgflip.com/2f6v9k.jpg" alt="Trulli" alt="Girl in a jacket" width="75%" height="75%"> ] --- layout: false class: inverse, middle, center # Introduction to SCED --- layout: true name:aims-slide background-image: url(uos.png), url(pearls.jpg) background-position:5% 95%, 98% 96% background-size: 110px 50px, 10% --- exclude: true # Brief history slide --- background-image: url(images/plot.png) background-position:50% 95% background-size: 50% 35% # Single case involves: -- + .blue[Scientific] approach to monitoring change/response to a given treatment. -- + .blue[Time-series] measurement (quantifiable + over time). -- + .blue[Baseline] period. -- + .blue[Experimental manipulation] of an IV. ??? + (i.e., introduce/remove/change treatment). + Experimental = 3+ manipulations + Less than this = quasi experimental. -- + Focus on .blue[within-subject] variability. --- background-image: url(AB.png) background-position:75% 50% background-size:80% 100% --- # What is a baseline? + .blue[Repeated measurements] before treatment is introduced. + The ideal is .blue[long and stable] baselines. --- exclude: true # Baseline requirements How long should the baseline be? Varies by discipline. Some argue that there should be stability (5% variability around mean) before progressing to intervention however this is not always essential (or realistic). When does the baseline end? (should be at a defined, planned point). A good place may be when providing the formulation (if using one). **Remember**! Your idiographic measures go from the start to end of the work. -- .pull-left[ .red[However:] + Not common. + Some disorders have inbuilt variability. + Are neutral baselines a fallacy? ] .pull-right[ <img src="https://media.makeameme.org/created/one-does-not-5ac35f.jpg" alt="Girl in a jacket" width="370" height="300"> ] --- # The focus? .large[ - Your .blue[individual] service user. - .blue[You], the clinician. - Why and what leads to change? - Within client change rather than across client change.] --- name: coffee class: inverse3, middle, center layout: false <svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:white;height:8em;" xmlns="http://www.w3.org/2000/svg"> <path d="M127.1 146.5c1.3 7.7 8 13.5 16 13.5h16.5c9.8 0 17.6-8.5 16.3-18-3.8-28.2-16.4-54.2-36.6-74.7-14.4-14.7-23.6-33.3-26.4-53.5C111.8 5.9 105 0 96.8 0H80.4C70.6 0 63 8.5 64.1 18c3.9 31.9 18 61.3 40.6 84.4 12 12.2 19.7 27.5 22.4 44.1zm112 0c1.3 7.7 8 13.5 16 13.5h16.5c9.8 0 17.6-8.5 16.3-18-3.8-28.2-16.4-54.2-36.6-74.7-14.4-14.7-23.6-33.3-26.4-53.5C223.8 5.9 217 0 208.8 0h-16.4c-9.8 0-17.5 8.5-16.3 18 3.9 31.9 18 61.3 40.6 84.4 12 12.2 19.7 27.5 22.4 44.1zM400 192H32c-17.7 0-32 14.3-32 32v192c0 53 43 96 96 96h192c53 0 96-43 96-96h16c61.8 0 112-50.2 112-112s-50.2-112-112-112zm0 160h-16v-96h16c26.5 0 48 21.5 48 48s-21.5 48-48 48z"></path></svg> --- name: why-slide class: inverse, middle, center # Why use SCEDs? --- layout: true background-image: url(uos.png), url(pearls.jpg) background-position:5% 95%, 98% 96% background-size: 110px 50px, 10% --- name: coffee --- # So why use SCEDs? -- .large[.red[<svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-blue);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M160 320h12v16c0 8.84 7.16 16 16 16h40c8.84 0 16-7.16 16-16v-16h12c17.67 0 32-14.33 32-32V64c0-17.67-14.33-32-32-32V16c0-8.84-7.16-16-16-16h-64c-8.84 0-16 7.16-16 16v16c-17.67 0-32 14.33-32 32v224c0 17.67 14.33 32 32 32zm304 128h-1.29C493.24 413.99 512 369.2 512 320c0-105.88-86.12-192-192-192v64c70.58 0 128 57.42 128 128s-57.42 128-128 128H48c-26.51 0-48 21.49-48 48 0 8.84 7.16 16 16 16h480c8.84 0 16-7.16 16-16 0-26.51-21.49-48-48-48zm-360-32h208c4.42 0 8-3.58 8-8v-16c0-4.42-3.58-8-8-8H104c-4.42 0-8 3.58-8 8v16c0 4.42 3.58 8 8 8z"></path></svg> **Clinical research:**] Testing clinical hypotheses and contributing to knowledge.] -- .large[.blue[<svg viewBox="0 0 480 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-blue);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M477.7 186.1L309.5 18.3c-3.1-3.1-8.2-3.1-11.3 0l-34 33.9c-3.1 3.1-3.1 8.2 0 11.3l11.2 11.1L33 316.5c-38.8 38.7-45.1 102-9.4 143.5 20.6 24 49.5 36 78.4 35.9 26.4 0 52.8-10 72.9-30.1l246.3-245.7 11.2 11.1c3.1 3.1 8.2 3.1 11.3 0l34-33.9c3.1-3 3.1-8.1 0-11.2zM318 256H161l148-147.7 78.5 78.3L318 256z"></path></svg> **Practice philosophy**:] Being a scientist practitioner.] -- .large[.orange[<svg viewBox="0 0 640 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-blue);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M256 336h-.02c0-16.18 1.34-8.73-85.05-181.51-17.65-35.29-68.19-35.36-85.87 0C-2.06 328.75.02 320.33.02 336H0c0 44.18 57.31 80 128 80s128-35.82 128-80zM128 176l72 144H56l72-144zm511.98 160c0-16.18 1.34-8.73-85.05-181.51-17.65-35.29-68.19-35.36-85.87 0-87.12 174.26-85.04 165.84-85.04 181.51H384c0 44.18 57.31 80 128 80s128-35.82 128-80h-.02zM440 320l72-144 72 144H440zm88 128H352V153.25c23.51-10.29 41.16-31.48 46.39-57.25H528c8.84 0 16-7.16 16-16V48c0-8.84-7.16-16-16-16H383.64C369.04 12.68 346.09 0 320 0s-49.04 12.68-63.64 32H112c-8.84 0-16 7.16-16 16v32c0 8.84 7.16 16 16 16h129.61c5.23 25.76 22.87 46.96 46.39 57.25V448H112c-8.84 0-16 7.16-16 16v32c0 8.84 7.16 16 16 16h416c8.84 0 16-7.16 16-16v-32c0-8.84-7.16-16-16-16z"></path></svg> **Accountability and evaluation:**] Being a effective practitioner and auditing your work.] -- .large[.pink[<svg viewBox="0 0 576 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-blue);height:1em;" xmlns="http://www.w3.org/2000/svg"> <path d="M542.22 32.05c-54.8 3.11-163.72 14.43-230.96 55.59-4.64 2.84-7.27 7.89-7.27 13.17v363.87c0 11.55 12.63 18.85 23.28 13.49 69.18-34.82 169.23-44.32 218.7-46.92 16.89-.89 30.02-14.43 30.02-30.66V62.75c.01-17.71-15.35-31.74-33.77-30.7zM264.73 87.64C197.5 46.48 88.58 35.17 33.78 32.05 15.36 31.01 0 45.04 0 62.75V400.6c0 16.24 13.13 29.78 30.02 30.66 49.49 2.6 149.59 12.11 218.77 46.95 10.62 5.35 23.21-1.94 23.21-13.46V100.63c0-5.29-2.62-10.14-7.27-12.99z"></path></svg> **Education and training:**] Learning SCED skills for the rest of your career] --- # Status of SCED as a research tool? .pull-left-narrow[<img src="https://i.vimeocdn.com/portrait/6782840_640x640" alt="Girl in a jacket" width="200" height="150"> <img src="https://pbs.twimg.com/media/E5lYBTZUYAEJucE?format=png&name=small" alt="Girl in a jacket" width="200" height="150">] .pull-right-wide[ + Highly .blue[accessible] for clinicians. + Growing .blue[popularity]. + Single case texts/books regularly published. + No longer restricted to ABA. + Health user movements. + Appropriate for novel or .blue[emerging] areas. + e.g. CBT and panic/psychosis rooted in SCED evidence. + RCTs are not the only option. + Rapidly developing field. + New analytical methods + designs.] --- background-image: url(https://johnlewis.scene7.com/is/image/JohnLewis/237518072) background-position: -20% 30% background-size: 600px 600px .pull-right-wide[ # Hour Glass Model Three stage research cycle for evidencing treatment (Salkovskis, 1995): 1. Practice based pilot studies on small *n* in routine services. 2. Highly controlled trials efficacy studies (e.g. RCTs). 3. Implementation studies (return treatment to routine settings.) .center[ <img src="https://www.babcp.com/portals/0/Images/Members/Picture2.png?ver=2021-03-11-165551-763" alt="Girl in a jacket" width="600" height="265"> <figcaption class="caption">Figure taken from interesting <a href="https://bpspsychub.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/papt.12278">BABCP article</a> </figcaption> ] ] --- background-image: url(https://www.its.ws/PublishingImages/Quality/Quality-data.jpg) background-position:100% 65% background-size: 45% 65% # Clinical Practice .pull-left[ + Accountability and evaluation. + Demonstrating treatment effectiveness. + Monitoring progress (or deterioration). + Training in single case methods makes more effective practitioners? + Referral on following ineffective treatment – you will really know this. + Inviting patient to be part of evaluation. ] --- exclude: true background-image: url(https://images.unsplash.com/photo-1588600878108-578307a3cc9d?ixid=MnwxMjA3fDB8MHxzZWFyY2h8MTR8fHJlc2VhcmNofGVufDB8fDB8fA%3D%3D&ixlib=rb-1.2.1&auto=format&fit=crop&w=500&q=60) background-position:85% 85% background-size: cover class: center, bottom ## .my-yellow[.my-hot-blue[Being a Scientific Practitioner]] --- # Scientific Practitioner .left[ Most useful contribution of SCED? Ability to answer questions that are .red[clinically relevant variants on those of evidence-based practice.]] -- .pull-left[ <figure class="quote"> <blockquote> .blue[ .large[ “Does this evidence-based treatment work for this particular client, who differs in some way from the sample characteristics of the evidence base?".]] <figcaption> </figure> ] --- # What’s the advantage of SCED? .pull-left[ .large[ - Low cost - Low infrastructure - Small ‘turning circle’ - Easily adaptable + flexible - Collaborative (if done right) ]] -- .pull-right[ .Large[.white[.my-hot-blue[**Available for all clinicians to use!**]]]. ] --- # Why don’t clinicians use it? -- .large[ + Lack of confidence + Lack of knowledge + Can be messy in practice - The ideal described in the classic texts on the design seems a far cry from what is possible in the real world. + Perception that it is too much for the recipient to handle - <a href="http://www.dgapractice.com/documents/meehl_case_conferences_adapted.pdf">Theory of Spun Glass</a> (Meehl, 1973) ] --- name: measures-slide class: center, middle background-image: url(https://images.unsplash.com/photo-1501516069922-a9982bd6f3bd?ixid=MnwxMjA3fDB8MHxzZWFyY2h8MXx8bWVhc3VyZXxlbnwwfHwwfHw%3D&ixlib=rb-1.2.1&auto=format&fit=crop&w=500&q=60) background-position:85% 85% background-size: cover # .my-yellow[.my-hot-blue[Approaches to Measurement]] --- class: center, top, split-three, .column.bg-main1[.content[ <img style="border-radius: 50%;" src=" " width="150px"/> ### Nomothetic Measures .fade[Traditional questionnaire approaches used in services.] ] .my-hot-pink[ - Attempts to generalise people. - Uses objective knowledge. - Based on data that is categorical or numerical. ] ] -- .column.bg-main2[.content[ <img style="border-radius: 50%;" src=" " width="150px"/> ### Idiographic Measures .fade[Unique measures applied in an individualised manner.] ] .my-hot-green[ - Focuses on recognition of uniqueness. - Uses subjective experience. - Based on study of uniqueness at an individual level. ] ] -- .column.bg-main3[.content[ <img style="border-radius: 50%;" src="" width="150px"/> ### Qualitative Approaches .fade[Qualitative approaches to assessment (e.g. interviews).]] .my-hot-red[ - like ideographics, focuses on subjective judgement and experience. - Traditional methods: interviews, focus groups, soft outcomes. ] ] .footnote[.center[ <a href="https://i.ytimg.com/vi/eiCSJL5zOng/maxresdefault.jpg">Adapted from </a> ]] --- # Ideographic or nomothetic? <p>SCED seeks to balance focus on nomothetic and idiographic approaches to measurement.</p> A funnel approach from nomothetic to idiographic target measures -- <figure class="quote"> <blockquote>.blue[ “Different but complementary approaches to accumulating a broader base of evidence... So, when asked by clinical trainees, what two outcome measures I would recommend, my response invariably is: one nomothetic and one idiographic".] <figcaption> — Barkham, 2016</cite> </figcaption> </figure> -- <p>Nomothetic and ideographic has long tradition within psychotherapy Sheffield University (e.g., Barkham, Stiles, & Shapiro, 1993).</p> .center[ <a href="https://eprints.whiterose.ac.uk/104190/1/Commentary%20on%20Alves%20and%20Sales%20final%20version.pdf"> Barkham commentary (2017) </a> ] --- https://dclinpsych.leeds.ac.uk/wp-content/uploads/sites/26/2019/03/Gary-Latchford-idiographic-day.pdf # Time series measurement + .blue[Frequent and systematic measurement] of outcome measures that are key to the maintenance of the clinical problem + In essence, you then ask to what extent the observed variation in the measures is consistent with change occurring? + The repeated measures provide data on the variation across time in these outcome. With this information the search can begin for the causes of that variation .center[ <img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS805ImzbghI67DjNetq3iij46BS0YdSuadlg&usqp=CAU" alt="Girl in a jacket" width="900" height="200"> ] --- # Using nomothetic measures + These are the questionnaires that are 'off the shelf' and often used for pre-post change. + Use them: + at the start/end of each phase. + at the end of follow-up (if you have that in your design). + Try to match one the nomothetic measure to the presenting problem + Is the measure you are using one of .blue[Effectiveness] + General psychological distress (e.g. CORE-OM, SCL-90, BSI, OQ-45, K-10). + Disorder specific (e.g. BDI, PHQ-9, GAD-7, YBOCS, IES). + Supplement with other measures? + Process? + Clinician rated? --- # Generalisation measures Whilst the intervention should influence the target of the intervention, an important issue is whether the intervention generalizes to other aspects of the client’s life. These measures are good test of the external validity of your work. You take these measures (e.g. quality of life) occasionally and often in tandem with the nomothetic outcomes measures. - Functioning (e.g. WSAS). - Health related quality of life - Life satisfaction --- # Qualitative approaches Qualitative approaches can also be profitably applied to the single-case design. The collection of rich, detailed qualitative information throughout the course of treatment can prove useful in helping to rule out alternative hypotheses --- exclude: true name: coffee class: inverse3, middle, center layout: false <svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:white;height:8em;" xmlns="http://www.w3.org/2000/svg"> <path d="M127.1 146.5c1.3 7.7 8 13.5 16 13.5h16.5c9.8 0 17.6-8.5 16.3-18-3.8-28.2-16.4-54.2-36.6-74.7-14.4-14.7-23.6-33.3-26.4-53.5C111.8 5.9 105 0 96.8 0H80.4C70.6 0 63 8.5 64.1 18c3.9 31.9 18 61.3 40.6 84.4 12 12.2 19.7 27.5 22.4 44.1zm112 0c1.3 7.7 8 13.5 16 13.5h16.5c9.8 0 17.6-8.5 16.3-18-3.8-28.2-16.4-54.2-36.6-74.7-14.4-14.7-23.6-33.3-26.4-53.5C223.8 5.9 217 0 208.8 0h-16.4c-9.8 0-17.5 8.5-16.3 18 3.9 31.9 18 61.3 40.6 84.4 12 12.2 19.7 27.5 22.4 44.1zM400 192H32c-17.7 0-32 14.3-32 32v192c0 53 43 96 96 96h192c53 0 96-43 96-96h16c61.8 0 112-50.2 112-112s-50.2-112-112-112zm0 160h-16v-96h16c26.5 0 48 21.5 48 48s-21.5 48-48 48z"></path></svg> --- background-image: url(https://i.imgflip.com/n7kko.jpg) background-position:100% 105% background-size: 60% 100% class: inverse # .my-hot-blue[Setting <br>up <br>idiographic <br>measures] --- # Designing idiographic measures: Steps .large[ Step 1) Agree upon the .blue[constructs] that need to change (e.g., compulsive checking). Step 2) Agree upon the .blue[scale of measurement] (e.g., checking frequency). Step 3) Agree how the information is going to be .blue[recorded] (e.g., daily diary self-report). ] --- # 1. Constructs - What to measure? .large[ - .blue[Anything!] (that matters to the patient). - From the start of the first appointment keep your eyes peeled. - Don't be afraid to offer suggestions or recommendations. - Could be a cognition, behaviour, affect or interpersonal process. - What does the patient, the family, the referrer want? - Miracle Question...? ] Design it collaboratively with your patient. Explain the reason why. --- # 2. Measurement scales .large[ .blue[Frequency] = Count data (e.g., number of checking behaviours). .blue[Intensity] = Quantifying severity (e.g., 1-10, high-medium-low). .blue[Duration] = Time (e.g., number of hours) .blue[Event Occurrence] = Binary event occurrence (did something happen or not) ] + The scale can influence the analyses available. Event occurrence is more supplementary. + Anchored and scaled effectively – let the client define this. --- # 3. How to record .large[ .blue[When to measure]: Daily? More? Less? .blue[Who measures]: Patient? Relative? Carer? Staff? .blue[Recording tool]: Pen and Paper? Template? Excel file? Smart phone? MS Forms? ] For an example of a MS tool click <a href="https://chris-gaskell.github.io/uos-sced/day-one/idiographic-diary.xlsx">here</a> --- layout: false class: inverse2, top, center # Practical Task .left[ ## **Setting up measures** .large[- Pick a case that you are working with (or have in the past)] .large[- Write a brief (three sentence max) bio/referral about the patient (presenting problems, relevant case info).] .large[- Develop **4 hypothetical idiographic measures** (remember to define the construct, the scale and establish how it will be recorded).] .large[- Pick **2 suitable nomothetic measures** (at what points should the patient complete them?) ] .large[Present back to the group]] .footnote[ .large[*10-15 minute discussion task in pairs] ] --- # Baseline trends + A worsening baseline (worsening of symptoms) may represent a temporary change that would dissipate regardless of any intervention. + An improving baseline may prevent confidence in saying whether subsequent improvement is due to intervention or natrual remission. + Stability also shows its not spontaneous recovery .blue[Ideally] the baseline should be stable (mean level) with low variability. Problems arise if baselines display: ( i ) Linear trends: (ii) Higher order trends (iii) High variability. Presence of these makes visual or statistical analysis more difficult **(but still possible)**. --- # Control measure + These are an idiographic measure, not expected to change due to the intervention + If there is change in the target idiographic measures and not the control is shows the intervention working. + Assessing specificity of effect on target measures. + Look at anxiety (green line) on the following plot as an example. --- background-image: url(control.png) background-position:120% 100% background-size: contain class: --- # How to engage clients + Not a must do aspect of your work + Provide the rationale + Have a relaxed attitude + Display interest in their plight + Be flexible + This is an aspect of your normal practice + Promise feedback --- layout: false class: inverse2, top, center # Role Play .left[ ## Practice setting up measures .Large[- **Modelling / role play**] .Large[- **Watch the demonstration then critique**] .Large[- **Practice in pairs**] ] --- name: coffee class: inverse3, middle, center layout: false <svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:white;height:8em;" xmlns="http://www.w3.org/2000/svg"> <path d="M127.1 146.5c1.3 7.7 8 13.5 16 13.5h16.5c9.8 0 17.6-8.5 16.3-18-3.8-28.2-16.4-54.2-36.6-74.7-14.4-14.7-23.6-33.3-26.4-53.5C111.8 5.9 105 0 96.8 0H80.4C70.6 0 63 8.5 64.1 18c3.9 31.9 18 61.3 40.6 84.4 12 12.2 19.7 27.5 22.4 44.1zm112 0c1.3 7.7 8 13.5 16 13.5h16.5c9.8 0 17.6-8.5 16.3-18-3.8-28.2-16.4-54.2-36.6-74.7-14.4-14.7-23.6-33.3-26.4-53.5C223.8 5.9 217 0 208.8 0h-16.4c-9.8 0-17.5 8.5-16.3 18 3.9 31.9 18 61.3 40.6 84.4 12 12.2 19.7 27.5 22.4 44.1zM400 192H32c-17.7 0-32 14.3-32 32v192c0 53 43 96 96 96h192c53 0 96-43 96-96h16c61.8 0 112-50.2 112-112s-50.2-112-112-112zm0 160h-16v-96h16c26.5 0 48 21.5 48 48s-21.5 48-48 48z"></path></svg> --- name: designs-slide class: inverse, middle, center # Designs --- layout: false class: inverse .panelset[ .panel[.panel-name[Designs] <!--Front--> .small[.pull-left-narrow[.white[Numerous SCED designs] - A = Baseline - B = Intervention - A2/W = Withdrawal - C = Alt. treatment - FU = Follow up Important to consider ethics and feasibility. Design influences strength of validity. ]] .pull-right-wide[ <img src="https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/87f59f64-c81a-4771-bd80-ec57c0da4c9a/gr1_lrg.jpg" alt="Girl in a jacket" width="" height="400">] ] .panel[.panel-name[A-B] <!--AB--> .small[ .pull-left-narrow[ - Most basic & accessible. - Improvement on simple pre-post - Low validity. - Quasi-experimental. - Leaves open many alternative explanations for observed change. ]] .pull-right-wide[ ### .center[Classic A-B Design] .center[ ![](plots_files/figure-html/AB-1.png) ] ] .right[ .small[For examples of studies using AB designs see <a href="https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F4ED9F2DD6363B66B0C18F6B4A3081B6/S1352465814000411a.pdf/transdiagnostic-cbt-treatment-of-co-morbid-anxiety-and-depression-in-an-older-adult-single-case-experimental-design.pdf">(Hague, 2015)</a> or <a href="https://eprints.whiterose.ac.uk/174906/3/Effectiveness%20of%20the%20unified%20protocol%20for%20treating%20co-morbid%20health%20anxiety%20and%20depression%20-%20an%20empirical%20case%20study.pdf">(Gaskell, 2021)</a>. ]] ] <!--A-B-FU Design--> .panel[.panel-name[A-B-FU] .pull-left-narrow[ .small[ - Multiple comparisons possible. - Can assess maintenance of gains. - stronger than A-B design. ]] .pull-right-wide[ ### .center[Integrating a follow-up] .center[ ![](plots_files/figure-html/ABFU-1.png) ] ] .right[ .small[For an example study using an AB follow up design see <a href="https://www.tandfonline.com/doi/pdf/10.1080/03069885.2021.1929834">(Kellett, 2021)</a>. ]] ] <!--A-B-FU Design--> .panel[.panel-name[A-B-A-B] .pull-left-narrow[ .small[ - Are the effects of the intervention durable? - What happens if the treatment is withdrawn? ]] .pull-right-wide[ ### .center[Using a withdrawal phase] .center[ ![](plots_files/figure-html/ABAB-1.png) ] ] .right[ .small[For an example study using an ABAB design see <a href="https://bpspsychub.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/papt.12278">(Kellett, 2021)</a>. ]] ] <!--A-B-A-C--> .panel[.panel-name[A-B-A-C] .pull-left-narrow[ .small[ - Comparing treatment effectiveness. – Seldom employed in psychotherapy . ]] .pull-right-wide[ ### .center[Alternating the treatment] .center[ ![](plots_files/figure-html/ABAC-1.png) ]] .right[.small[For an example study using an ABC design see <a href="https://www.cambridge.org/core/services/aop-cambridge-core/content/view/2997836636C01A6766138701F889AB8C/S1352465820000521a.pdf/treatment_of_compulsive_buying_disorder_comparing_the_effectiveness_of_cognitive_behavioural_therapy_with_personcentred_experiential_counselling.pdf">(Kellett, 2021)</a>.]] ] ] <!--Panel-Set-End--> --- # Considerations with withdrawal designs Ask yourself "am I being ethical and so are reversals or withdrawals appropriate?". Important to know the methodological features before you start (see the later planning slide) .pull-left[ ### Theoretical consdiderations .small[ + Are treatments reversible? + Carry-over effects. + Therapeutic instructions (e.g. self-control / management strategies) + long-acting pharmacological interventions; + altered environments & staff attitudes. ]] .pull-right[ ### Ethical considerations .small[ + Prior agreement with client/staff needed, along with consent. + Brief withdrawal phase and rapid re-instatement of treatment + Client's expectations and adherence to withdrawal + Treatment holidays? ]] --- # Threats to validity 1. History (extraneous concurrent events) 2. Maturation (spontaneous recovery) 3. Testing (reactivity and the mere measurement effect) 4. Instrumentation (reliability) 5. Multiple intervention problems (can a psychotherapy be withdrawn)? 6. Instability --- # Multi-component interventions + Borkovec and Castonguay (2006) point out, the use of mini-interventions in which circumscribed components of treatment are actively manipulated is an underused research strategy, but one that offers the opportunity to increase our knowledge of basic change mechanisms in psychological treatments. + Separate out the modules on the time series graphs and test for an effect. For assignment submit the excel sheets as part of the submission showing each module and the scores on the idiographic measures during the phases --- # Planning your design + Start planning and designing from the referral letter. + Write a plan and take it to supervision Things to consider: + The type of design + The number of sessions in each phase and module + How the phases will be sequenced with the modules + Frequency of the idiographic measures + Frequency of the nomothetic and generalisation measures + Frequency, duration, place and time of sessions + Baseline fidelity (be able to describe in full detail) + Treatment fidelity (how to keep everything the same bar starting treatment). --- name: stages-slide class: inverse, middle, center # Stages of SCED --- class: inverse, center, top # The stages of a SCED .left[.large[.white[ 1. Identify question and hypothesis. 2. Select appropriate design and measures. 3. identify materials and resources. 4. Collect data/supervise study. 5. Analysis .small[(covered in day 2)] 6. Interpretation. 7. Communication/dissemintation. ]] .footnote[These stages may need to be considered collectively and not in isolation. For example. The level of communication of findings may determine the level of analysis adopted.]] --- # Identify clinical question and hypotheses Hypotheses can be developed as soon as you have any sense of what the subject of change could be (referral letter? Clinical notes? First session?). **Considerations**: - How do the hypotheses fit the psychological formulation? - Are there any treatment textbooks that are going to be important? - Is the clinical problem compatible with the therapy as described in the treatment manual? - State the hypotheses clearly! - State any therapeutic predictions clearly! .blue[Example:] That CBT will lead to a reduction in 'hurting myself' (idiographic) as measured daily, and also a reduction in overall depression as measured through the PHQ-9 (nomothetic). --- # Identify measures - What measures are required to assess the therapeutic aims and goals? - Nomothetic before/after each phase? - Idiographics daily throughout? Ensure measures are suitable for SCED. In practice this usually means: - Observational measures such as time sampling and staff checklists on in-patient ward - daily diaries of symptoms, functioning, problem resolution - Regular use of short psychometric questionnaires etc. - Ensure rating scales are unambiguously worded and are anchored and well described. --- # Identify measures - Ensure that diaries are well laid out and well presented. - Scraps of paper do not value people and are seldom completed! - 1 page per day? per week? per month? - Consider using a combination of measures targeted at both symptoms and functioning. - Consider several sources of measurements: client and partner/carer, child and parent, - Consider use of follow ups phase; A/B-FU design --- # Materials & Resources Ensure measures are acceptable/appropriate for client, or staff or carer or partner. Plan for study to be feasibly matched to realities of NHS clinical practice: - baseline collected across sessions 1-2? - Intervention starts session 3, 16 sessions of therapy contracted - follow ups at 6 weeks and 6 months? Ensure quality of adequate resources Staff need to be properly briefed: - Patients need to know what they need to do. - Supervisor aware of coursework. - Any involved staff on wards are briefed. --- # Materials & Resources If staff are collecting the data do they understand the design rationale and do they need any training? Data should be recorded and stored reliably (i.e. it is being written down in a retrievable manner, it is not missing and is confidential). If appropriate, staff should receive ongoing feedback about progress of the case (i.e. regular review meetings) and this be reported in the method. What are the consequences of diverting resources to this project in relation to other ongoing clinical work? Is it feasible in the setting your working in? --- # Interpretation - What are the main changes or effects? - How do they correspond to predictions? - Are they valid given the design? - What alternative explanations (i.e. threats to validity) are there? - Are the effects reliable or clinical significant? Are they noticeable to therapist, client or others? - Are they generalizable or clinically replicable? - If effects are clinically nonsignificant - what explanations exist? --- # Communication and dissemination .large[ - Share the findings with the client and/or the staff member. - Thank client and staff. There are robust research findings demonstrating that... Feeding back outcomes to patients during treatment leads to greater outcomes. **Particularly** for patients who are not on track. ] --- # Conclusions - SCED can be used in a wide variety of situations and these range across service users and settings. - As trainee scientist-practitioners – a good place to be. - Integrate the methods into your practice – don’t be anxious. - Always start with the baseline - the design can evolve and be flexible - This is still all about your client. Your job is to help them, not t merely manipulate variables and phases. - Play around with the methodology --- class: inverse, middle, center # End of Day one